Neuroanatomical changes in Parkinson's disease in relation to cognition: An update

The pathophysiological changes underlying impairment of cognition in Parkinson′s disease (PD) are complex and not fully understood till date. Hence, understanding the structural changes responsible for cognitive decline in PD is essential for early diagnosis and to offer effective treatment. In this review, we discuss the neuroanatomical changes in major brain structures responsible for cognition in PD. We have included the key findings of various studies to provide up-to-date information for better understanding of pathophysiology of PD, which will help researchers and clinicians in planning and developing new treatment methods for the benefit of PD patients.

[1]  N. Schiff,et al.  Cognitive enhancement with central thalamic electrical stimulation , 2006, Proceedings of the National Academy of Sciences.

[2]  T. Sejnowski,et al.  Glial Biology in Learning and Cognition , 2014, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[3]  D. Burn,et al.  Magnetic resonance imaging: A biomarker for cognitive impairment in Parkinson's disease? , 2013, Movement disorders : official journal of the Movement Disorder Society.

[4]  E. Hirsch,et al.  Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism. , 2006, Brain : a journal of neurology.

[5]  P. Cavallari,et al.  Human Neuroscience Hypothesis and Theory Article a Role for Locus Coeruleus in Parkinson Tremor , 2022 .

[6]  J. Jankovic,et al.  Variable expression of Parkinson's disease , 1990, Neurology.

[7]  J. P. Rushton,et al.  Whole Brain Size and General Mental Ability: A Review , 2009, The International journal of neuroscience.

[8]  C. Büchel,et al.  Structural findings in the basal ganglia in genetically determined and idiopathic Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[9]  David J. Brooks,et al.  Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: An in vivo 11C-raclopride PET study , 2008, Experimental Neurology.

[10]  R. Barker,et al.  Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease , 2016, Movement disorders : official journal of the Movement Disorder Society.

[11]  F. Delis,et al.  Dopamine transporters in the cerebellum of mutant mice , 2008, The Cerebellum.

[12]  Kurt Jellinger,et al.  Amygdala pathology in Parkinson's disease , 2004, Acta Neuropathologica.

[13]  K. Jellinger.  Neuropathology of movement disorders. , 1998, Neurosurgery clinics of North America.

[14]  J. Kulisevsky,et al.  Changes in artistic style and behaviour in Parkinson’s disease: dopamine and creativity , 2009, Journal of Neurology.

[15]  J. Tanabe,et al.  Microstructural Changes within the Basal Ganglia Differ between Parkinson Disease Subtypes , 2016, Front. Neuroanat..

[16]  R. Camicioli,et al.  Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia , 2004, Neuroscience Letters.

[17]  A. Gjedde,et al.  A deformation‐based morphometry study of patients with early‐stage Parkinson’s disease , 2010, European journal of neurology.

[18]  Weizhong Tian,et al.  Changes of brain gray matter structure in Parkinson's disease patients with dementia , 2013, Neural regeneration research.

[19]  S H Lee,et al.  Regional Volume Analysis of the Parkinson Disease Brain in Early Disease Stage: Gray Matter, White Matter, Striatum, and Thalamus , 2011, American Journal of Neuroradiology.

[20]  Catherine J. Stoodley,et al.  The Cerebellum and Cognition: Evidence from Functional Imaging Studies , 2011, The Cerebellum.

[21]  R. Barker,et al.  Mild cognitive impairment in Parkinson disease , 2010, Neurology.

[22]  Nishant Goyal,et al.  Neuropsychology of prefrontal cortex , 2008, Indian journal of psychiatry.

[23]  F. Meneghello,et al.  Brain volume changes in Parkinson's disease and their relationship with cognitive and behavioural abnormalities , 2011, Journal of the Neurological Sciences.

[24]  J. Obeso,et al.  Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[25]  Fuxiang Chen,et al.  Altered regional homogeneity of prefrontal cortex in Parkinson’s disease with mild cognitive impairment , 2016, Chinese Neurosurgical Journal.

[26]  E Bertrand,et al.  Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease. , 1997, Folia neuropathologica.

[27]  D. Voronkov,et al.  Changes in Neuroglial Interactions in Nigrostriatal Brain Structures on Modeling of Dopamine System Dysfunction , 2014, Neuroscience and Behavioral Physiology.

[28]  O. Abe,et al.  White Matter Alteration of the Cingulum in Parkinson Disease with and without Dementia: Evaluation by Diffusion Tensor Tract–Specific Analysis , 2012, American Journal of Neuroradiology.

[29]  M. Hallett,et al.  The cerebellum in Parkinson’s disease , 2013, Brain : a journal of neurology.

[30]  S. Aglioti.  THE ROLE OF THE THALAMUS AND BASAL GANGLIA IN HUMAN COGNITION , 1997, Journal of Neurolinguistics.

[31]  D. Vaillancourt,et al.  Thalamic Projection Fiber Integrity in de novo Parkinson Disease , 2013, American Journal of Neuroradiology.

[32]  J. Massano,et al.  Cognitive Impairment and Dementia in Parkinson’s Disease: Clinical Features, Diagnosis, and Management , 2012, Front. Neur..

[33]  B. MacVicar,et al.  Neurone-glia interactions in the hypothalamus and pituitary , 1996, Trends in Neurosciences.

[34]  R. Mindham,et al.  Mortality in Parkinson's disease and its association with dementia and depression , 2004, Acta neurologica Scandinavica.

[35]  V. Rajmohan,et al.  The limbic system , 2007, Indian journal of psychiatry.

[36]  E. Evarts,et al.  Lesions of ascending dopaminergic pathways decrease forebrain glucose uptake , 1976, Nature.

[37]  Rafeef Abugharbieh,et al.  Shape (but not volume) changes in the thalami in Parkinson disease , 2008, BMC neurology.

[38]  S. Oliet,et al.  Activity-dependent structural and functional plasticity of astrocyte-neuron interactions. , 2008, Physiological reviews.

[39]  L. Forsgren,et al.  The relation between cognition and motor dysfunction in drug‐naive newly diagnosed patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[40]  M. Vila,et al.  The role of glial cells in Parkinson's disease , 2001, Current opinion in neurology.

[41]  Cristina Tassorelli,et al.  Functional changes of the basal ganglia circuitry in Parkinson's disease , 2000, Progress in Neurobiology.

[42]  G. Halliday.  Thalamic changes in Parkinson's disease. , 2009, Parkinsonism & related disorders.

[43]  K. Jellinger.  The association of incident dementia with mortality in PD , 2003, Neurology.

[44]  Y. Smith,et al.  Neuroglial Plasticity at Striatal Glutamatergic Synapses in Parkinson's Disease , 2011, Front. Syst. Neurosci..

[45]  W. Weiner.  Parkinson’s Disease and Movement Disorders , 2000, Current Clinical Practice.

[46]  Gerry Leisman,et al.  Clinical Motor and Cognitive Neurobehavioral Relationships in the Basal Ganglia , 2013 .

[47]  F. Skidmore,et al.  White Matter Microstructure Changes in the Thalamus in Parkinson Disease with Depression: A Diffusion Tensor MR Imaging Study , 2010, American Journal of Neuroradiology.

[48]  Antonio Cerasa,et al.  Increased prefrontal volume in PD with levodopa‐induced dyskinesias: A voxel‐based morphometry study , 2011, Movement disorders : official journal of the Movement Disorder Society.

[49]  Leonard Petrucelli,et al.  Molecular pathogenesis of Parkinson disease. , 2005, Archives of neurology.

[50]  J. E. Bell,et al.  Evidence of a breakdown of corticostriatal connections in Parkinson’s disease , 2005, Neuroscience.

[51]  L. Brown,et al.  Sensory and cognitive functions of the basal ganglia , 1997, Current Opinion in Neurobiology.

[52]  R. Barker,et al.  Movement Disorders , 1994, Stereotactic and Functional Neurosurgery.

[53]  A. Schrag,et al.  Mild Cognitive Impairment in Parkinson’s Disease—What Is It? , 2018, Current Neurology and Neuroscience Reports.

[54]  K. Jellinger.  Neuropathology of Movement Disorders , 1998 .

[55]  R. Iacono,et al.  The hypothalamus in Parkinson Disease , 1987, The Italian Journal of Neurological Sciences.